26S proteasomes and immunoproteasomes produce mainly N-extended versions of an antigenic peptide

EMBO Journal

Volumn 20, Issue 10, 2001, Pages 2357-2366

  Cascio, Paolo ^a   Hilton, Craig ^b   Kisselev, Alexei F ^a   Rock, Kenneth L ^b   Goldberg, Alfred L ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Antigen processing; Immunoproteasomes; MHC class I; Proteasomes; Protein degradation

Indexed keywords

AMINOPEPTIDASE; ANTIGEN; EPITOPE; GAMMA INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; OVALBUMIN; PEPTIDE; PROTEASOME;

AMINO TERMINAL SEQUENCE; ANTIGEN PRESENTATION; ARTICLE; BETA CHAIN; CARBOXY TERMINAL SEQUENCE; ENZYME SPECIFICITY; PRIORITY JOURNAL; PROTEIN DEGRADATION;

NON-PROGRAMMATIC;

ANIMALS; ANTIGENS; EGG PROTEINS; EPITOPES, B-LYMPHOCYTE; HYBRIDOMAS; IMMUNODOMINANT EPITOPES; MICE; OVALBUMIN; PEPTIDE BIOSYNTHESIS; PEPTIDE HYDROLASES; PEPTIDES; PROTEASOME ENDOPEPTIDASE COMPLEX;

EID: 0035873704     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1093/emboj/20.10.2357     Document Type: Article

References (43)

1. Akopian, T.N., Kisselev, A.F. and Goldberg, A.L. (1997) Processive degradation of proteins and other catalytic properties of the proteasome from Thermoplasma acidophilum. J. Biol. Chem., 272, 1791-1798.
2. Benaroudj, N. and Goldberg, A.L. (2000) PAN, the proteasome-activating nucleotidase from archaebacteria, is a protein-unfolding molecular chaperone. Nature Cell Biol., 2, 833-839.
3. Beninga, J., Rock, K.L. and Goldberg, A.L. (1998) Interferon-γ can stimulate post-proteasomal trimming of the N terminus of an antigenic peptide by inducing leucine aminopeptidase. J. Biol. Chem., 273, 18734-18742.
4. Ben-Shahar, S., Komlosh, A., Nadav, E., Shaked, I., Ziv, T., Admon, A., DeMartino, G.N. and Reiss, Y. (1999) 26 S proteasome-mediated production of an authentic major histocompatibility class I-restricted epitope from an intact protein substrate. J. Biol. Chem., 274, 21963-21972.
5. Cardozo, C. and Kohanski, R.A. (1998) Altered properties of the branched chain amino acid-preferring activity contribute to increased cleavages after branched chain residues by the 'immunoproteasome'. J Biol. Chem., 273, 16764-16770.
6. Craiu, A., Akopian, T., Goldberg, A. and Rock, K.L. (1997) Two distinct proteolytic processes in the generation of a major histocompatibility complex class I-presented peptide. Proc. Natl Acad. Sci. USA, 94, 10850-10855.
7. Dick, L.R. et al. (1994) Proteolytic processing of ovalbumin and β-galactosidase by the proteasome to yield antigenic peptides. J. Immunol., 152, 3884-3894.
8. Dick, T.P., Stevanovic, S., Keilholz, W., Ruppert, T., Koszinowski, U., Schild, H. and Rammensee, H.G. (1998) The making of the dominant MHC class I ligand SYFPEITHI. Eur. J. Immunol., 28, 2478-2486.
9. Dolenc, I., Seemuller, E. and Baumeister, W. (1998) Decelerated degradation of short peptides by the 20S proteasome. FEBS Lett., 434, 357-361.
10. Eleuteri, A.M., Kohanski, R.A., Cardozo, C. and Orlowski, M. (1997) Bovine spleen multicatalytic proteinase complex (proteasome) -replacement of X, Y and Z subunits by Lmp7, Lmp2 and Mecl1 and changes in properties and specificity. J. Biol. Chem., 272, 11824-11831.
11. Emmerich, N.P., Nussbaum, A.K., Stevanovic, S., Priemer, M., Toes, R.E., Rammensee, H.G. and Schild, H. (2000) The human 26 S and 20 S proteasomes generate overlapping but different sets of peptide fragments from a model protein substrate. J. Biol. Chem., 275, 21140-21148.
12. Falk, K., Rotzschke, O. and Rammensee, H.G. (1990) Cellular peptide composition governed by major histocompatibility complex class I molecules. Nature, 348, 248-251.
13. Gaczynska, M., Rock, K.L. and Goldberg, A.L. (1993) γ-interferon and expression of MHC genes regulate peptide hydrolysis by proteasomes. Nature, 365, 264-267.
14. Groettrup, M., Ruppert, T., Kuehn, L., Seeger, M., Standera, S., Koszinowski, U. and Kloetzel, P.M. (1995) The interferon-γ-inducible 11 S regulator (Pa28) and the Lmp2/Lmp7 subunits govern the peptide production by the 20 S proteasome in vitro. J. Biol. Chem., 270, 23808-23815.
15. Hilton, C.J., Dahl, A.M. and Rock, K.L. (2001) Anti-peptide antibody blocks peptide binding to MHC class I molecules in the endoplasmic reticulum. J. Immunol., 166, 3952-3956.
16. Hirs, C.H.W. (1967) Performic acid oxidation. Methods Enzymol., 11, 197-198.
17. Kisselev, A.F., Akopian, T.N., Woo, K.M. and Goldberg, A.L. (1999) The sizes of peptides generated from protein by mammalian 26 and 20 S proteasomes. Implications for understanding the degradative mechanism and antigen presentation. J. Biol. Chem., 274, 3363-3371.
18. Lauvau, G., Kakimi, K., Niedermann, G., Ostankovitch, M., Yotnda, P., Firat, H., Chisari, F.V. and van Endert, P.M. (1999) Human transporters associated with antigen processing (TAPs) select epitope precursor peptides for processing in the endoplasmic reticulum and presentation to T cells. J. Exp. Med., 190, 1227-1239.
19. Lucchiari-Hartz, M., van Endert, P.M., Lauvau, G., Maier, R., Meyerhans, A., Mann, D., Eichmann, K. and Niedermann, G. (2000) Cytotoxic T lymphocyte epitopes of HIV-1 Nef: generation of multiple definitive major histocompatibility complex class I ligands by proteasomes. J. Exp. Med., 191, 239-252.
20. Michalek, M.T., Grant, E.P., Gramm, C., Goldberg, A.L. and Rock, K.L. (1993) A role for the ubiquitin-dependent proteolytic pathway in MHC class I-restricted antigen presentation. Nature, 363, 552-554.
21. Michalek, M.T., Grant, E.P. and Rock, K.L. (1996) Chemical denaturation and modification of ovalbumin alters its dependence on ubiquitin conjugation for class I antigen presentation. J. Immunol., 157, 617-624.
22. Mo, X.Y., Cascio, P., Lemerise, K., Goldberg, A.L. and Rock, K. (1999) Distinct proteolytic processes generate the C and N termini of MHC class I-binding peptides. J. Immunol., 163, 5851-5859.
23. Mo, A.X., van Lelyveld S.F., Craiu, A. and Rock, K.L. (2000) Sequences that flank subdominant and cryptic epitopes influence the proteolytic generation of MHC class I-presented peptides. J. Immunol., 164, 4003-4010.
24. Momburg, F., Roelse, J., Hammerling, G.J. and Neefjes, J.J. (1994) Peptide size selection by the major istocompatibility complex-encoded peptide transporter. J. Exp. Med., 179, 1613-1623.
25. Niedermann, G., Butz, S., Ihlenfeldt, H.G., Grimm, R., Lucchiari, M., Hoschutzky, H., Jung, G., Maier, B. and Eichmann, K. (1995) Contribution of proteasome-mediated proteolysis to the hierarchy of epitopes presented by major histocompatibility complex class I molecules. Immunity, 2, 289-299.
26. Niedermann, G., Geier, E., Lucchiari-Hartz, M., Hitziger, N., Ramsperger, A. and Eichmann, K. (1999) The specificity of proteasomes: impact on MHC class I processing and presentation of antigens. Immunol. Rev., 172, 29-48.
27. Pamer, E. and Cresswell, P. (1998) Mechanisms of MHC class I-restricted antigen processing. Annu. Rev. Immunol., 16, 323-358.
28. Paz, P., Brouwenstijn, N., Perry, R. and Shastri, N. (1999) Discrete proteolytic intermediates in the MHC class I antigen processing pathway and MHC I-dependent peptide trimming in the ER. Immunity, 11, 241-251.
29. Reits, A.J., Vos, J.C., Gromme, M. and Neefjes J. (2000) The major substrates for TAP in vivo are derived from newly synthesized proteins. Nature, 404, 774-778.
30. Rock, K.L. and Goldberg, A.L. (1999) Degradation of cell proteins and the generation of MHC class I-presented peptides. Annu. Rev. Immunol., 17, 739-779.
31. Rock, K.L., Rothstein, L. and Gamble, S. (1990) Generation of class I MHC-restricted T-T hybridomas. J. Immunol., 145, 804-811.
32. Rock, K.L., Gramm, C., Rothstein, L., Clark, K., Stein, R., Dick, L., Hwang, D. and Goldberg, A.L. (1994) Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules. Cell, 78, 761-771.
33. Schubert, U., Anton, L., Gibbs, J., Norbury, C., Yewdell, J.W. and Bennink, J.R. (2000) Rapid degradation of a large fraction of newly synthesized proteins by proteasomes. Nature, 404, 770-774.
34. Schwarz, K., van Den Broek, M., Kostka, S., Kraft, R., Soza, A., Schmidtke, G., Kloetzel, P.M. and Groettrup, M. (2000) Overexpression of the proteasome subunits LMP2, LMP7 and MECL-1, but not PA28 α/β. enhances the presentation of an immunodominant lymphocytic choriomeningitis virus T cell epitope. J. Immunol., 165, 768-778.
35. Sewell, A.K., Price, D.A., Teisserenc, H., Booth, B.L., Jr, Gileadi, U., Flavin, F.M., Trowsdale, J., Phillips, R.E. and Cerundolo, V. (1999) IFN-γ exposes a cryptic cytotoxic T lymphocyte epitope in HIV-1 reverse transcriptase. J. Immunol., 162, 7075-7079.
36. Sijts, A.J., Ruppert, T., Rehermann, B., Schmidt, M., Koszinowski, U. and Kloetzel, P.M. (2000) Efficient generation of a hepatitis B virus cytotoxic T lymphocyte epitope requires the structural features of immunoproteasomes. J. Exp. Med., 191, 503-514.
37. Snyder, H.L., Yewdell, J.W. and Bennink, J.R. (1994) Trimming of antigenic peptides in an early secretory compartment. J. Exp. Med., 180, 2389-2394.
38. Sloltze, L., Dick, T.P., Deeg, M., Pommerl, B., Rammensee, H.G. and Schild, H. (1998) Generation of the vesicular stomatitis virus nucleoprotein cytotoxic T lymphocyte epitope requires proteasome-dependent and -independent proteolytic activities. Eur. J. Immunol., 28, 4029-4036.
39. Stoltze, L. et al. (2000) Two new proteases in the MHC class I processing pathway. Nature Immunol., 1, 413-418.
40. 2+-free calmodulin and calmodulin damaged by in vitro aging are selectively degraded by 26S proteasomes without ubiquitination. J. Biol. Chem., 275, 20295-20301.
41. Van Kaer, L., Ashtonrickardt, P.G., Eichelberger, M., Gaczynska, M., Nagashima, K., Rock, K.L., Goldberg, A.L., Doherty, P.C. and Tonegawa, S. (1994) Altered peptidase and viral-specific T-cell response in LMP2 mutant mice. Immunity, 1, 533-541.
42. Verma, R. and Deshaies, R.J. (2000) A proteasome howdunit: the case of the missing signal. Cell, 101, 341-344.
43. Yewdell, J.T. and Bennink, J.R. (1999) Immunodominance in major histocompatibility complex class I-restricted T lymphocyte responses. Annu. Rev. Immunol., 17, 51-88.